2m 2m 2m 2m 2m 2m 2m
ENLIVEN THERP (ELVN)
NASDAQ
$59.84+$0.02 (+0.03%)
Price as of Aug 21, 2026 7:30 PM EDT- $4.4BMarket Cap
- 186.91%1-Year Change
- BiotechnologyIndustry
ENLIVEN THERP (ELVN)
$59.84+$0.02 (+0.03%)
ELVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.82 | ||
Change | +$0.90 (+1.53%) | ||
Open | $59.00 | ||
High | $60.00 | ||
Low | $58.83 | ||
Previous Close | $58.92 | ||
Volume | 596,369 | ||
30-Day Average Volume | 987,380 | ||
1-Week Change | 1.70% | ||
1-Month Change | 10.10% | ||
1-Year Change | 186.91% | ||
3-Year Change | 255.01% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $910.2M | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.6M | ||
EBIT | -$32.5M | ||
EBITDA | -$32.5M | ||
Net Working Capital | $893.2M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -131 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -122 | ||
PEG | 4 | ||
Price/Free Cash Flow | -235 | ||
Price/Operating Cash Flow | -237 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue